Abiopharma

Arrowhead Pharmaceuticals to Participate in Upcoming January 2026 Events

Zai Lab Announces Approval of COBENFY (xanomeline and trospium chloride) in China, a First-in-Class Therapy for Schizophrenia

Bausch + Lomb to Participate in the 44th Annual J.P. Morgan Healthcare Conference

Dyne Therapeutics Appoints Vikram Karnani to Board of Directors

Invivyd Earns Fast Track Designation for VYD2311, a Vaccine-Alternative Antibody to Prevent COVID

Invivyd Announces Initiation of DECLARATION Clinical Trial, a Phase 3 Placebo-Controlled Pivotal Study of VYD2311, a Vaccine-Alternative Antibody to Prevent COVID

Bio-Techne to Present at the 2026 J.P. Morgan Healthcare Conference

Precision BioSciences Announces Grant of Inducement Awards Under Nasdaq Listing Rule 5635(c)(4)

EUDA Accelerates Longevity Strategy with Launch of Comprehensive Stem Cell Therapy Platform and First Clinic in Shenzhen

AtaiBeckley Added to the Nasdaq Biotechnology Index (NBI)